Additionally, hepatic steatosis and metabolic parameters were assessed to determine the impact of TRF.<h4>Results</h4>No differences were observed in the incidence, size, or distribution of GSTP-positive lesions in the liver or ACF in the colon between TRF and AdL groups. This evidence concerns the gene GSTP1 and fatty liver disease.